KIRK SHEPARD

home>About us > Leadership

Board of Directors

KIRK SHEPARD (MAPS Director)

[vc_row][vc_column][vc_custom_heading text=”CMO, Head of Global Medical Affairs, SVP OBG” el_class=”leader_inner_heading”][vc_custom_heading text=”Eisai” el_class=”leader_inner_heading-2″][vc_column_text el_class=”leader_content”]Dr. Kirk Shepard has more than 25 years of experience in the pharmaceutical industry. He is a board-certified medical oncologist and hematologist physician. He is currently Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs OBG at Eisai Pharmaceutical Company.

Dr. Shepard’s experience in multiple therapeutic areas includes operational and strategic product development from Phases I through IV and the diverse disciplines of medical affairs and product commercialization, such as leading compliance and SOP/policy efforts, health economics & outcomes research & patient access, data generation, field-based medical teams (MSLs), PV/safety, medical communication & publications, patient advocacy, and public relations. In 2015, he was selected as one of the 100 Most Inspiring People in the Pharmaceutical Industry (PharmaVOICE).

Before his pharmaceutical career, Dr. Shepard served as a staff physician in the Department of Hematology and Medical Oncology at the Cleveland Clinic Foundation, where he supervised numerous studies in oncology and symptom control. He has more than 50 medical publications in journals and books. Dr. Shepard earned his bachelor’s degree from Cornell University in Ithaca, NY, and his medical degree from the University of Cincinnati Medical School in Cincinnati, OH. He completed both his internship and residency in internal medicine at Case Western Reserve University in Cleveland, OH, and fellowships in hematology and oncology at the University of Chicago Hospitals and Clinics in Chicago, IL.[/vc_column_text][/vc_column][/vc_row]